Literature DB >> 32069156

Insulin Pumps.

Rayhan Lal1, Lalantha Leelarathna2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32069156      PMCID： PMC7207015          DOI： 10.1089/dia.2020.2502

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


× No keyword cloud information.
  21 in total

Review 1.  Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Authors:  Hsin-Chieh Yeh; Todd T Brown; Nisa Maruthur; Padmini Ranasinghe; Zackary Berger; Yong D Suh; Lisa M Wilson; Elisabeth B Haberl; Jessica Brick; Eric B Bass; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

2.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

3.  Armanni-Ebstein Lesions in Terminal Hyperglycemia.

Authors:  Chong Zhou; Andrea J Yool; Roger W Byard
Journal:  J Forensic Sci       Date:  2016-12-16       Impact factor: 1.832

4.  Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.

Authors:  Bartlomiej Matejko; Katarzyna Cyganek; Barbara Katra; Danuta Galicka-Latala; Malgorzata Grzanka; Maciej T Malecki; Tomasz Klupa
Journal:  Rev Diabet Stud       Date:  2011-08-10

5.  Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.

Authors:  Beate Karges; Anke Schwandt; Bettina Heidtmann; Olga Kordonouri; Elisabeth Binder; Ulrike Schierloh; Claudia Boettcher; Thomas Kapellen; Joachim Rosenbauer; Reinhard W Holl
Journal:  JAMA       Date:  2017-10-10       Impact factor: 56.272

6.  Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.

Authors:  Mary B Abraham; Jennifer A Nicholas; Grant J Smith; Janice M Fairchild; Bruce R King; Geoffrey R Ambler; Fergus J Cameron; Elizabeth A Davis; Timothy W Jones
Journal:  Diabetes Care       Date:  2017-11-30       Impact factor: 19.112

7.  Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.

Authors:  Isabelle Steineck; Jan Cederholm; Björn Eliasson; Araz Rawshani; Katarina Eeg-Olofsson; Ann-Marie Svensson; Björn Zethelius; Tarik Avdic; Mona Landin-Olsson; Johan Jendle; Soffia Gudbjörnsdóttir
Journal:  BMJ       Date:  2015-06-22

8.  Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial.

Authors:  Chantal Mathieu; Bruce W Bode; Edward Franek; Athena Philis-Tsimikas; Ludger Rose; Tina Graungaard; Anne Birk Østerskov; David Russell-Jones
Journal:  Diabetes Obes Metab       Date:  2018-02-04       Impact factor: 6.577

9.  Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.

Authors:  Guido Freckmann; Ulrike Kamecke; Delia Waldenmaier; Cornelia Haug; Ralph Ziegler
Journal:  Diabetes Technol Ther       Date:  2019-03-22       Impact factor: 6.118

10.  A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).

Authors:  David C Klonoff; Mark L Evans; Wendy Lane; Hans-Peter Kempe; Eric Renard; J Hans DeVries; Tina Graungaard; Agon Hyseni; Theis Gondolf; Tadej Battelino
Journal:  Diabetes Obes Metab       Date:  2019-01-13       Impact factor: 6.577
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.